OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NUVI.PK56

Aroom Inc

Investment Management & Fund OperatorsVerified

Aroom Inc has a negative equity position of -$60.42 million and no cash on its balance sheet, resulting in a current ratio of 0.0, indicating severe liquidity constraints. The company's debt-to-equity ratio is -0.22, reflecting a capital structure dominated by liabilities with no equity buffer. The return on equity of 14.68% is mathematically high due to negative equity, but this is not indicative of financial health. The company's operating and net income are both -$8.87 million, showing consistent losses. These losses are not offset by any operating cash flow, and the company has no revenue streams to support its operations. The absence of positive financial performance metrics suggests the company is not generating value for shareholders and is operating at a loss. Aroom Inc's revenue is concentrated in its ME4Free business division, which sells non-prescription herbal products and sexual health capsules. There is no disclosed geographic diversification, and the company's operations are entirely Web-based, with no physical retail presence or distribution channels beyond its website. The company has no disclosed revenue growth in recent periods and is expected to continue operating at a loss. The lack of positive financial performance and absence of a clear path to profitability suggest the company is not on a growth trajectory. The risk assessment indicates medium liquidity risk and low dilution risk, but the company's negative net cash position is a key flag. Recent filings and transcripts do not disclose any material events or strategic shifts. The company remains in a development stage with no clear milestones or product launches that would indicate a path to profitability.

30-day price · NUVI.PK(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyAroom Inc
TickerNUVI.PK
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryInvestment Management & Fund Operators
AI analysis

Business. Aroom Inc is a development-stage company focused on health and beauty care through the Web, offering an Android Set-top-box and non-prescription herbal products via its ME4Free division, and marketing sexual health capsules through www.me4free.net.

Classification. Aroom Inc is classified under Financials > Banking & Investment Services > Investment Management & Fund Operators with 92% confidence.

Aroom Inc has a negative equity position of -$60.42 million and no cash on its balance sheet, resulting in a current ratio of 0.0, indicating severe liquidity constraints. The company's debt-to-equity ratio is -0.22, reflecting a capital structure dominated by liabilities with no equity buffer. The return on equity of 14.68% is mathematically high due to negative equity, but this is not indicative of financial health. The company's operating and net income are both -$8.87 million, showing consistent losses. These losses are not offset by any operating cash flow, and the company has no revenue streams to support its operations. The absence of positive financial performance metrics suggests the company is not generating value for shareholders and is operating at a loss. Aroom Inc's revenue is concentrated in its ME4Free business division, which sells non-prescription herbal products and sexual health capsules. There is no disclosed geographic diversification, and the company's operations are entirely Web-based, with no physical retail presence or distribution channels beyond its website. The company has no disclosed revenue growth in recent periods and is expected to continue operating at a loss. The lack of positive financial performance and absence of a clear path to profitability suggest the company is not on a growth trajectory. The risk assessment indicates medium liquidity risk and low dilution risk, but the company's negative net cash position is a key flag. Recent filings and transcripts do not disclose any material events or strategic shifts. The company remains in a development stage with no clear milestones or product launches that would indicate a path to profitability.
Key takeaways
  • Aroom Inc has no cash and a negative equity position, indicating severe liquidity constraints.
  • The company is operating at a loss with no positive operating cash flow.
  • Revenue is concentrated in a single business division with no geographic diversification.
  • The company has no clear path to profitability and is expected to continue operating at a loss.
  • The risk assessment highlights medium liquidity risk and a negative net cash position.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income-$8.9k
Net income-$8.9k
R&D
SG&A
D&A
SBC
Operating cash flow$0.00
CapEx
Free cash flow
Total assets$0.00
Total liabilities$60.4k
Total equity-$60.4k
Cash & equivalents$0.00
Long-term debt$13.4k
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$60.4k
Net cash-$13.4k
Current ratio0.0
Debt/Equity-0.2
ROA
ROE14.7%
Cash conversion-0.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Banking & Investment Services · cohort 10 companies
MetricNUVI.PKActivity
Op margin26.6% medp25 13.9% · p75 29.0%
Net margin18.8% medp25 13.7% · p75 22.7%
Gross margin67.6% medp25 41.5% · p75 93.2%
CapEx / revenue1.2% medp25 0.4% · p75 1.9%
Debt / equity-22.0%7.7% medp25 7.7% · p75 7.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-03 22:45 UTC#d2782bc5
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 22:46 UTCJob: 320ef788